Results 171 to 180 of about 57,669 (284)

Opposite kinetics of L-leucine and L-phenylalanine induced insulin release studies with the perfused rat pancreas [PDF]

, 1972
Landgraf, R., Landgraf-Leurs, M. M. C., Schwarz, K., Scriba, Peter Christian   +3 more
core  

Picture living with diabetes: A photovoice study of young adults' efforts in making diabetes care fit into their lives

Diabetic Medicine, Volume 43, Issue 5, May 2026.
Abstract Aim This study aimed to identify what young adults with type 1 diabetes (T1D) do to make diabetes care fit in their lives and the impact of diabetes and diabetes care on living. Methods Dutch young adults with T1D (18–30 years old) submitted photographed real‐life situations of efforts to make care fit and of the impact of care on their lives.
Anka Van Gastel, Matthijs Graner‐Baars, Eelco J. P. De Koning, Victor M. Montori, Viet‐Thi Tran, Sean F. Dinneen, Jessica Mesman, Joris Swaak, Henk‐Jan Aanstoot, Anne M. Stiggelbout, Marleen Kunneman   +10 more
wiley   +1 more source

Euthyroid Sick Syndrome as a Predictor of Hospital Stay in Pediatric Diabetic Ketoacidosis. [PDF]

J Clin Med
Alqahtani YA, A Shati A, Alshaikh AA, Alasmari AHN, Alghamdi FA, Alamri NA, Summan SI, Atif OMA, Ghazy RM.   +8 more
europepmc   +1 more source

New Opportunities Beyond Intensive Insulin Therapy for Improving Vascular Health of People Living With Type 1 Diabetes

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Djordje S. Popovic, Zoltan Kender, Theocharis Koufakis   +2 more
wiley   +1 more source

Improving glycaemic outcomes with subsidised access to diabetes technology in a young adult population with type 1 diabetes

Diabetic Medicine, Volume 43, Issue 5, May 2026.
Abstract Aims The availability of diabetes technologies has increased, although access can be limited for young people with type 1 diabetes (T1D). In Australia, access to subsidised continuous glucose monitors (CGM) has expanded significantly, while insulin pump access remains limited.
Andrew‐Hyun Lee, Gabrielle Stokes, Kaye Farrell, Deborah Jane Holmes‐Walker   +3 more
wiley   +1 more source

Decision accuracy of simultaneously used real‐time CGM versus intermittently scanned CGM around exercise in type 1 diabetes: A secondary analysis of the ULTRAFLEXI‐1 study

Diabetic Medicine, Volume 43, Issue 5, May 2026.
Abstract Aims Continuous glucose monitoring (CGM) systems have become important technologies to improve glycaemia in people with type 1 diabetes (T1D). However, it has been shown that during rapid glucose change, sensor performance can deteriorate.
Sabrina Sanfilippo, Alexander Müller, Felix Aberer, Faisal Aziz, Harald Kojzar, Caren Sourij, Ulrike Leb‐Stöger, Philipp Birnbaumer, Peter N. Pferschy, Norbert Tripolt, Harald Sourij, Othmar Moser   +11 more
wiley   +1 more source

Risk of recurrent diabetic ketoacidosis following initiation of sodium-glucose co-transporter 2 inhibitors in patients with an insulin-deficient diabetes and prior diabetic ketoacidosis: An observational cohort study. [PDF]

Diabetes Obes Metab
Tsur A, Hamtzany O, Pollack R, Cahn A.
europepmc   +1 more source

Diabetes management in people undergoing metabolic‐bariatric surgery: A guideline from the Joint British Diabetes Societies for Inpatient Care (JBDS‐IP) Group

Diabetic Medicine, Volume 43, Issue 5, May 2026.
Abstract The global prevalence of obesity and diabetes continues to rise, with metabolic‐bariatric surgery recognised as an effective intervention for obesity and type 2 diabetes, offering potential for type 2 diabetes remission and improved glycaemic control. This guideline, developed by the Joint British Diabetes Societies for Inpatient Care (JBDS‐IP)
Jeffrey W. Stephens, Ketan Dhatariya, Andrew J. Beamish, Dimitri J. Pournaras, Alexander D. Miras, Nader Raafat, Georgia Noble‐Bell, Rachel Cadwallader Buckland, Omar G. Mustafa   +8 more
wiley   +1 more source

A Case of Euglycemic Diabetic Ketoacidosis With Tirzepatide Use and Severe Calorie Restriction. [PDF]

JCEM Case Rep
Raptis D, Theodoropoulos P, Shah MK, Bloomgarden N, Kishore P.   +4 more
europepmc   +1 more source

Rethinking control‐IQ+ technology: Simple strategies for easy optimization

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3502-3514, May 2026.
Abstract Control‐IQ+ is an automated insulin delivery (AID) algorithm approved for people with type 1 diabetes aged 2+ years and adults aged 18+ years with type 2 diabetes. While numerous publications support improved glycaemia and quality of life for people with diabetes, this practice paper is intended to encourage uptake for healthcare professionals
Viral N. Shah, Pratik Choudhary, Ilana Halperin, Ivana Rabbone, Dessi P. Zaharieva, Laurel Messer   +5 more
wiley   +1 more source